Last reviewed · How we verify

NCT03476265: DYSMOSTIM

Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motility

Completed NA Last updated 5 July 2019
What this trial tests

NA trial testing Electrical Stimulation of the Lower Esophageal Sphincter in Quality of Life in 17 participants. Completed in 15 June 2018.

Timeline
1 May 2017
Primary endpoint
15 January 2018
15 June 2018

Quick facts

Lead sponsorAustrian Society Of Surgical Oncology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment17
Start date1 May 2017
Primary completion15 January 2018
Estimated completion15 June 2018
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Austrian Society Of Surgical Oncology

Who can join

Adults 18 to 80, any sex, with Quality of Life or Dysphagia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate gastroesophageal reflux disease - health related quality of life (GERD-HRQL) after electrical stimulation of the lower esophageal sphincter (LES) in patients with gastroesophageal reflux disease (GERD) and esophageal dysmotility.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility.
    Paireder M, Kristo I, Asari R, Jomrich G, et al · · 2021 · cited 5× · PMID 33128080 · DOI 10.1007/s00464-020-08104-3

Verify or expand the search:

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other Austrian Society Of Surgical Oncology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03476265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing